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Objective To audit our results of dorsal buccal mucosal 
graft urethroplasty for recurrent bulbar urethral stricture 
disease and compare them with those from specialist 
centres. 
Patients and methods Data were collected prospectively on 
52 men who had urethroplasty with ≥€1 year of follow-up; 
failure was defined as the need for further intervention. 
Results The mean (range) age of the patients was 39 (19–
61) years and 23 (45%) had an identifiable cause for their 
stricture. The mean (range) stricture length was 3.5 (1.5–
6) cm and was associated with moderate or severe 
spongiofibrosis in 38 (73%) men. Ten (19%) men had minor 
complications after surgery. The mean (range) follow-up 
was 34 (12–80) months,with the mean maximum urinary 
flow rate increasing from 6 to 24 mL/s after surgery. The 
surgery failed, requiring dilatation or urethrotomy, in seven 
(14%) men at a mean (range) of 25 (15–50) months after 
urethroplasty, giving an overall success rate of 86%. 
Conclusion This prospective audit of dorsal buccal patch 
augmentation urethroplasty for bulbar strictures shows an 
equivalent outcome to the standard set by the expert 
originators, suggesting that is transferable to less specialized 
centres. The efficacy, low complication rate, short hospital 
stay and general applicability of the technique encourage its 
use for all men with recurrent bulbar stricture disease, but 
formal comparison with other options in randomized trials, 
including cost-effectiveness analysis, is needed. 
Keywords buccal mucosal graft, urethroplasty, urethral 
stricture 
Introduction 
Urethral stricture is a relatively common condition, with an 
estimated prevalence of 40 per 100 000 men at risk [1] and 
results in ≈€20 000 hospital admissions annually in the UK 
[2]. Strictures are caused by excessive scarring after mucosal 
injury [3] and the bulbar segment of the anterior urethra 
represents the commonest site, accounting for more than a 
third of patients undergoing reconstructive surgery [4]. 
Affected men generally present with a deteriorating urinary 
stream, confirmed by a reduced maximum urinary flow rate 
(Qmax) and flattened flow curve on uroflowmetry. The 
location, length and severity of the stricture can then be 
determined by endoscopic, radiographic or ultrasonographic 
assessment. Since the introduction of cold-knife optical 
urethrotomy [5], initial treatment is generally by endoscopic 
division, but the long-term recurrence rate is more than half 
[6]. Repeated urethrotomies will not cure the problem, 
although the stricture-free interval can be extended by 
regular self-dilatation [7]. 
Urethroplasty, using an anastomotic or augmentation 
technique, results in a considerably longer stricture-free 
interval and might have a higher cure rate, but its routine use 
has been discouraged by the relatively high cost, lack of an 
ideal graft material and the need for specialized surgical 
care. Two recent developments have resulted in a re-
examination of the urethroplasty option; the use of buccal 
mucosa grafts in an augmentation patch technique with no 
division of the urethra [8]; and managed-care pathways 
encouraging early mobilization and reduced hospital stay. 
Case series from specialist centres have shown good results 
but it remains uncertain whether such outcomes can be 
reproduced in less specialized units. We therefore 
prospectively audited the process and outcome of buccal 
graft dorsal patch bulbar urethroplasty against the expert 
standard, to judge the transferability of the technique and the 
need for appropriately designed comparative trials. 
Patients and methods 
We prospectively audited 52 consecutive men who had a 
single-stage buccal patch dorsal bulbar urethroplasty using 
the Barbagli technique [8], between October 1999 and 
February 2006. We were unable to collect outcome data 
from three men who could not be contacted following their 
surgery.  These men were marked as censored at 12 months 
on the Kaplan-Meyer plot and were otherwise excluded 
from outcome analysis. Selection criteria were isolated 
bulbar segment disease, recurrence after at least one 
previous urethrotomy, > 2 cm of diseased urethra, and 
appropriate fitness for anaesthesia. The anonymized patient 
database was updated regularly to include details of 
presentation, operation and short- and long-term follow-up. 
Routine follow-up was by patient report of symptoms and 
uroflowmetry, expressed as Qmax. Imaging was only used for 
suspected recurrence, and failure was defined as the need for 
further intervention for the bulbar stricture. 
The men were generally admitted to hospital on the day 
of surgery and given one preoperative prophylactic dose of 
antibiotic. A 6 × 2 cm buccal mucosa graft was harvested 
from the left inner cheek, avoiding the parotid duct orifice. 
Initially the oral mucosa was sutured closed, whereas in later 
cases the wound was left open after diathermy haemostasis. 
The bulbar urethra was exposed through a longitudinal 
perineal incision, mobilized from its dorsal attachments and 
a dorsal urethrotomy performed centred on the strictured 
area, with no division of the urethra but extending 
proximally and distally 0.5 cm beyond visible mucosal 
change and spongiofibrosis. Stricture length was then 
measured and degree of spongiofibrosis assessed by 
inspection and palpation.  The graft was prepared and 
sutured against the underlying corpora for stability, before 
being incorporated into the urethra as a dorsal patch. After 
wound closure a 16 F Silastic urethral catheter was left in 
situ for 3 weeks, at which stage a check retrograde 
urethrogram was taken before removing the catheter. 
Ambulation was encouraged after the first day after surgery 
and patients were generally discharged home on the second 
day. The follow-up was by outpatient or telephone review at 
3 months and then yearly thereafter. 
Results 
The mean (range) age of the men was 39 (19–61) years. A 
clear aetiological factor for stricture disease was identifiable 
in 23 (45%) men (Table 1). All men had had previous 
urethral dilatation, optical urethrotomy or urethroplasty with 
the mean (range) number of procedures being 3 (1–15) and 
20 (38%) were or had been self-dilating before surgery. In 
the six men with previous urethroplasty, either an 
anastomotic (three) scrotal flap (one), Blandy (one) or 
buccal patch (one) technique had been used. Before surgery 
the mean (SD) Qmax was 6.3 (5.1) mL/s, including six men 
(12%) who were unable to void (Qmax of 0) and were being 
managed by indwelling suprapubic catheterization, but 
excluding seven men with no recorded preoperative flow 
rate. 
The mean (SD, range) theatre time was 3.6 (0.7, 1.5–5) h 
and the mean (SD) stricture length measured during surgery 
was 3.5 (1.4) cm. Moderate or severe spongiofibrosis was 
seen in 73% of cases, with the stricture predominantly in the 
proximal and middle thirds of the bulbar urethra. There were 
complications after surgery in 10 patients (19%), and 
included: local wound infections in seven, of which one 
abscess required drainage; one scrotal haematoma; one 
idiopathic scrotal swelling; and one prolonged lower limb 
myalgia. The urethral catheter was removed after a check 
urethrogram at 3 weeks in 42 (81%) of men, whilst in 10 
there were leaks which delayed catheter removal by 1–
3 weeks. 
All patients are currently > 1 years from surgery and the 
mean (SD, range) follow-up was 34 (16.6, 12–80) months. 
At the last visit all but three patients were happy with their 
urinary flow, including those requiring subsequent 
dilatation, whilst two have bothersome postvoid dribbling 
and one persistent cheek soreness. Information on erectile 
function was recorded for 49 men, of whom 10 (20%) 
complained of erectile dysfunction (ED) before 
urethroplasty. After surgery, a further three men reported the 
new onset of ED, of whom one was diagnosed with type 1 
diabetes. By contrast, two men with previous ED reported 
resolution after urethroplasty. 
The mean (SD) flow rate at last visit was 24 (12.3) mL/s, 
vs 6.3 (5.1) mL/s before surgery. All six men with 
indwelling suprapubic catheters before surgery were 
catheter-free afterward. 
To date seven men (14%) have required further treatment 
for recurrent bulbar urethral stricture with a mean (range) 
time to re-treatment of 25 (15–50) months (Fig. 1, Table 2). 
Four men had optical urethrotomy and two had urethral 
dilatation for stricturing at the distal or proximal end of the 
graft, with two requiring a second procedure during the 
follow-up interval. There was no association between failure 
and the number of previous urethrotomies, but for all the 
degree of clinical spongiofibrosis was graded as moderate or 
severe. 
Discussion 
This study shows that the standard of efficacy for buccal 
patch urethroplasty in bulbar stricture disease as 
documented by leaders in the field can be achieved by a less 
experienced urologist, and suggests that the technique is 
transferable across different centres. Although cohort 
studies such as the present are graded low in evidence-based 
medicine terms, they remain of value for less common 
conditions or treatments, to establish standards of outcome 
on which personal or institutional audits can be based. They 
also add impetus and useful data for the design and conduct 
of multicentre controlled trials, which are needed to 
establish the optimum treatment of primary and recurrent 
bulbar urethral stricture disease. 
Several previous studies evaluated the outcome of bulbar 
augmentation urethroplasty using buccal grafts (Table 3) [9–
12] with 80–97% of men being stricture-free for periods of 
2–4 years. Other series suggested that most failures occur in 
the first year, implicating technical operative errors [11,13], 
whereas the present data suggest a peak at 2 years. Later 
failure is less common but it seems inevitable that the 
urethra of most men treated will remain ‘stricture-prone’, 
giving a substantial risk of recurrence or new stricture 
formation throughout their lifetime [14]. The current 
prospective study shows that our results are in line with the 
experience of leading urethral surgeons, and this should 
encourage others to audit their results and help to establish 
the technique as a routine option in the management of all 
men with bulbar strictures. 
The cause of treatment failure remains uncertain but 
might result from poor healing and graft incorporation at 
one or other end of the patch. This could be caused by poor 
graft ‘take’, deficient vascularity of the graft bed, poor 
surgical placement of apical sutures, or insufficient 
dissection proximal and distal to the stricture site to expose 
normal healthy underlying urethral mucosa [15]. 
Interestingly, all the patients who had a re-stricture in the 
present study had moderate or severe spongiofibrosis, which 
might imply poor vascularity of the adjacent spongiosum as 
a cause. Irrespective of the aetiology, current expert opinion 
suggests that fibrous ‘ring’ strictures at the proximal or 
distal end of the graft site often respond to either a simple 
dilatation or urethrotomy [15,16]. However, the poor long-
term results of repeated intraluminal treatments suggest that 
recurrence is likely given a sufficiently long follow-up 
[17,18]. 
In the present study information about sexual function 
before and after surgery was obtained by simple enquiry, 
with no formal completion of a sexual function 
questionnaire. As noted in previous series, changes in sexual 
function are uncommon and inconsistent, showing both 
deterioration and improvement. There is no anatomical 
reason why bulbar urethroplasty should alter sexual 
function, although associated haematoma, discomfort and 
psychological distress might cause temporary problems. In 
keeping with this view, a previous questionnaire study found 
that the risk of ED after anterior urethroplasty was similar to 
that after circumcision [19]. A more recent study showed no 
overall deterioration in erectile function or sex drive after 
surgery, although older men appeared more likely to 
experience ED [20]. Perhaps the most surprising finding in 
the present men was the relatively high rate of pre-existing 
ED in this relatively young population (20%). 
We feel that despite the methodological constraints, the 
present case series is a useful addition to publications on 
augmentation urethroplasty using buccal grafts. It 
prospectively recorded the outcome of the procedure 
performed by one surgeon, in a well-defined patient group, 
and used a standard consistent operative technique. We did 
not image the urethra during the follow-up but relied on 
patient-reported symptoms and the subsequent need for 
further procedures to define failure. This has the advantage 
of being patient-centred and therefore of most value in cost-
effectiveness terms, but might have missed subclinical 
structuring of the repaired augmented segment of the 
urethra. We did not use formal questionnaires to gain a 
semi-objective quantification of outcome, as none has been 
validated for this purpose. Buccal mucosa has been shown 
to be an effective and versatile graft material for the urethra, 
and in our experience rarely results in adverse effects from 
the donor site, except for one patient with persistent mouth 
soreness. The time in theatre was relatively long, but 
included patient preparation and consecutive rather than 
synchronous graft harvesting. To maintain consistency we 
placed the graft dorsally in all cases, as originally described 
by Barbagli et al. [9], although there is no evidence that this 
is superior to a lateral or ventral location. The dorsal 
approach has the advantage of maintaining continuity of the 
corpus spongiosum, although access for suturing of the 
urethral edge to the graft can be restricted. 
In conclusion, in many general centres the treatment of 
men with bulbar urethral stricture disease continues to be by 
repeated urethrotomy and teaching self-dilatation, which is 
minimally invasive but has poor long-term success [17,18]. 
The evidence from several case series, including the present 
study, is that augmentation urethroplasty represents a useful 
alternative. Some researchers suggest that for short bulbar 
urethral strictures a primary anastomotic urethroplasty is 
more cost-effective than internal urethrotomy [21,22], and 
others suggest that an initial single urethrotomy or dilatation 
followed by urethroplasty in those with recurrent disease 
might be a cost-efficient strategy [23]. We now need to 
establish with certainty which method of management is 
cost-effective and preferred by patients, and this can only be 
done, given the relative rarity of the disease, by conducting a 
well-controlled, prospective multicentre trial. 
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Fig. 1. A Kaplan-Meier survival plot showing the mean (full 
line with diamonds) patency rates during the follow-up, with 
95% CI (broken lines with squares). Table 2 shows number of 
men available for inclusion in the analysis at each time point. 
Table 1 Aetiology of bulbar urethral stricture 
Cause % of men 
Idiopathic 55 
Previous catheterization 17 
Trauma 6 
Urethral infection 12 
After TURP 2 
Previous hypospadias repair 6 
Lichen sclerosus 2 
Table 2 The number of men available for inclusion in the 
Kaplan-Meier analysis in Fig. 1. *Men lost to follow up 
following surgery. 
 Follow-up, months 
 ——————————————— 
Category 12 24 36 48 60 72 
At risk 52 49 26 16 8 4 
Censored 3* 19 8 8 3 3 
Failed 0 4 2 0 1 0 
Table 3 Published case series of buccal mucosal graft bulbar urethroplasty 
  Graft No. of Mean age, Follow-up, Success Time to  
Study Year placement patients years months rate (%) recurrence, months 
[9] 2005 Dorsal/ventral 50 42 42 84 * 
[10] 2001 Dorsal/ventral 77 31 > 24 89 * 
[11] 2003 Dorsal/ventral 65 41 41 97 10 
[12] 2001 Dorsal 20 52 13 80 * 
Present 2007 Dorsal 52 39 34 86 25 
*Not given 
 
